NCT05494684 Effectiveness of Multisensoral Nature-based Intervention in Hospitalized Children During Venous Blood Sampling
| NCT ID | NCT05494684 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oulu |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 106 participants |
| Start Date | 2026-12-01 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 106 participants in total. It began in 2026-12-01 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial (RCT) study aims to evaluate the effectiveness of multisensoral nature-based intervention compare to standard care in relieving anxiety, fear and pain in hospitalized child aged 5 to 9 years and parent's anxiety and satisfaction during venous blood sampling. The assessment uses different measures to assess child's anxiety, fear, pain and parent's anxiety and satisfaction during venous blood sampling. The study also measures the time spent on blood sampling.
Eligibility Criteria
Inclusion Criteria: 1. The child is aged between 5 and 9 years old 2. The child has a long-term illness (such as diabetes or rheumatism) 3. The child has previous experience of venous blood sampling 4. The child's level of development is age-appropriate (such as, the child is cared for at home or in day care/day nursery or attends school in the same level as the other children) 5. Child and parent understand and speak the Finnish language Exclusion Criteria: 1. The child has a diagnosis of abnormal neurological development (such as, a child has difficulty understanding spoken language or expressing emotions) 2. The child has chronic pain that has lasted more than 3 months and requires strong painkillers (opiates). 3. The child undergoes an examination or treatment during a check-up at the outpatient clinic that requires medical treatment similar to anesthesia 4. The child is taking a sedative medication.
Contact & Investigator
Saija Huhtala
PRINCIPAL INVESTIGATOR
Oulu University
Frequently Asked Questions
Who can join the NCT05494684 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 9 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05494684 currently recruiting?
Yes, NCT05494684 is actively recruiting participants. Contact the research team at saijahuhtala76@gmail.com for enrollment information.
Where is the NCT05494684 trial being conducted?
This trial is being conducted at Oulu, Finland.
Who is sponsoring the NCT05494684 clinical trial?
NCT05494684 is sponsored by University of Oulu. The principal investigator is Saija Huhtala at Oulu University. The trial plans to enroll 106 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.